The FDA cGMP for dietary supplements — identity testing on every incoming component, MMR/BPR, quality unit sign-off on every batch.

FSMA's cornerstone food rule — replaces the old 21 CFR 110 cGMP and adds Hazard Analysis & Risk-Based Preventive Controls (HARPC), PCQI, food-defense and supply-chain programmes.

FDA's umbrella cGMP regulation for drug products — sets scope, definitions and the regulatory status of Part 211.

The FDA cGMP rule that governs every step of finished-drug manufacturing — facilities, equipment, components, production, packaging, labels, lab controls, records and complaints.

FDA cGMP rule for Positron Emission Tomography (PET) drugs — short half-life specific.

FDA's GLP regulation — the quality system for nonclinical (animal/in-vitro) safety studies that support drug, device and food submissions.

FDA's regulation for mandatory adverse-event reporting by device manufacturers, importers and user facilities — the MDR rule.

The FDA's cGMP for finished medical devices — design controls, document control, production, CAPA and the DHR. Being harmonised with ISO 13485 as QMSR (effective Feb 2026).

FDA rule that defines when electronic records and e-signatures are trustworthy enough to replace paper.

Root-cause analysis technique — repeatedly ask 'why?' until you hit a systemic cause, not a symptom. Usually 4–6 iterations, not literally five.

The FDA pathway to market for most moderate-risk medical devices — demonstrate substantial equivalence to a legally-marketed predicate device. ~3,000 clearances per year.

Toyota's workplace-organisation foundation under every lean technique — engineers the floor so abnormalities are visible at a glance and the regulated standards (clean, orderly, identified, controlled) hold up between formal audits.

Ford-developed eight-step problem-solving methodology used widely in automotive, aerospace and contract manufacturing. Mandatory format for many customer complaints.

Toyota / Shook one-page (A3, 297×420 mm) visual PDCA artefact — four canonical types (problem-solving, proposal, status, information) — that forces an author to integrate background, current condition, target, root-cause analysis, countermeasure and follow-up into a single coherent argument, while the coaching dialogue around it develops problem-solvers at scale.

The radiation-safety principle: keep occupational and public exposure as low as reasonably achievable, social and economic factors considered. Foundational to NRC 10 CFR 20 and global radiation-protection regimes.

The nine-letter mnemonic regulators use to grade your data integrity — and what every Part 11 audit really tests.

The preventive-control programme covering the 9 major US allergens (FDA FALCPA + sesame as 9th) — segregation, scheduling, cleaning validation, label control, training.

Toyota's stop-the-line escalation signal — a kiosk channel that pages the right responder the moment an operator hits a problem, runs MTTA/MTTR clocks, and auto-promotes events into deviation, maintenance, EHS or CAPA records.

ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica) is the Argentine Republic's national regulatory authority for human + veterinary medicines + biologicals + vaccines + medical devices + IVDs + cosmetics + food + dietary supplements.

The EU GMP chapter that mandates VMP, DQ, IQ, OQ, PQ, PPQ and on-going verification for every regulated EU manufacturer.

ANPM / DPM (Agence Nationale du Médicament / Direction de la Pharmacie et du Médicament — Tunisia) is the Republic of Tunisia's national regulatory authority for human medicines + biologicals + vaccines + medical devices…

ANPP (Agence Nationale des Produits Pharmaceutiques — Algeria) is the People's Democratic Republic of Algeria's autonomous national regulatory authority for human medicines + biologicals + vaccines + medical devices + IV…

Brazil's national health-surveillance agency — regulator for pharmaceuticals, medical devices, food, cosmetics and sanitisers under Law 9.782/1999.

The substance in a drug that produces the intended pharmacological effect — the regulated 'drug' itself, before formulation with excipients. Manufactured to ICH Q7 GMP.

The once-a-year, product-by-product lifecycle review required by 21 CFR 211.180(e) (US) and EU GMP Chapter 1 §1.10 (EU) — covering every batch, deviation, OOS, change, complaint and stability time-point in the period, with a signed conclusion on whether the process is still in a state of control.

Statistical sampling plan used at incoming and finished-goods inspection — defined by ANSI/ASQ Z1.4 (or ISO 2859). The AQL is the worst-acceptable defect rate the plan will routinely pass.

ARCSA (Agencia Nacional de Regulación, Control y Vigilancia Sanitaria — Dr.

Two independent measurement sets captured at every calibration event against the same traceable reference: as-found = readings BEFORE any adjustment (drift evidence — what the instrument was telling the floor since the last cal); as-left = readings AFTER any adjustment (forward confidence — what it will tell the floor from now). As-found OOT auto-triggers §211.192 back-impact assessment of every batch since the previous as-left. Three-tier tolerance (as-left tightest + adjustment-trigger middle + as-found in-use widest) gives early-warning before OOT. Pass/fail-only templates are a §211.68 + §211.194 + Annex 11 §9 deficiency — raw readings per test-point are the evidence.

Recalculating the dispensed quantity of an active ingredient at weigh-out so the batch delivers 100% label-claim potency despite the actual lot assaying above or below reference. The standard remedy for assay variability across API/active lots under 21 CFR 211.101 and 211.103.

End-to-end management of regulated equipment from procurement and qualification through calibration, PM, change control, retirement and disposal.

End-to-end process of planning, executing, recording and following up on internal, supplier and regulatory audits — and routing findings to CAPA.

Tamper-evident log of who changed what, when, and why — required by Part 11.

Generic term for the per-batch evidence document — called BMR in pharma, BPR in supplements, DHR in medical devices.

Tracking material at the smallest physical container unit (bin / IBC / drum / pail / tote / sub-container) — not just lot level. A lot with 12 IBCs means a lot-only system pulls all 12 on recall; bin-level pulls the one affected + traces forward only to consuming batches. Four primitives: container_id (GS1 SSCC default) + parent_lot_id + state (intact/opened/consumed/split/merged/scrapped/returned/quarantined/re-packed/under-investigation) + event_chain (receipt → put-away → moves → opens → sub-charges → returns → close-out). Eleven events captured per container with operator + supervisor + QA e-sigs where required. Postgres recursive CTE walks forward + backward in ≤2 s on 50M-row event tables; as-of-timestamp snapshots replay historical graph state. Merge of penicillin + cytotoxic + hormone + live-biologic RLS-blocked. §211.184 + 211.196 + 820.65 + 820.198 + 111.260(g) + 111.610 + FSMA 204 KDE/CTE + EU FMD + DSCSA + UDI all converge. 2024 FDA 483 cited $14M unnecessary recall scope when 15 of 17 lots were unaffected because traceability was lot-level only.

Pre-sterilisation viable microbial count (USP <61>/<62> for pharma, ISO 11737-1 for devices) — used to size the sterilisation cycle, set in-process alert limits and confirm upstream microbiological control.

The signed record proving one specific batch was made exactly to the approved Master Manufacturing Record.

The structured list of every component required to make one unit of finished product — quantities, units, scrap factors, alternates. The foundation of MRP, costing and dispense.

FDA dietary-supplement equivalent of a BMR — the per-batch evidence under 21 CFR 111.

GFSI-recognised food-safety standard — most common in UK and EU food retailing.

Structured investigation + fix loop for recurring problems — required by every quality regime.

The post-implementation verification that a corrective or preventive action actually fixed the root cause — required by 21 CFR 820.100(a)(4), ICH Q10 and ISO 13485 §8.5.2-§8.5.3.

Ratio R = tolerance ÷ d (or equivalently the rule d ≤ tolerance ÷ 10) that decides whether a balance can physically distinguish in-band from out-of-band weighments. Baseline R ≥ 10 (AIAG MSA + ISO 22514-7 gauge-R&R guidance — measurement variability consumes ≤10% of tolerance budget). R = 4-10 is a caution band requiring documented ICH Q9(R1) QRM. R < 4 is mathematically unresolvable — every weighment lands 'in-band' regardless of true value. Two views: R_d (resolution-based, fast pre-flight) and R_σ (repeatability-based, environment-aware). The WO-release engine must recompute capability per release using the POST-adjustment target — caching R against nominal hides environment-driven σ_rep drift.

Deterministic, instrumental integrity testing (vacuum decay, HVLD, mass extraction, helium leak) against a product-specific Maximum Allowable Leakage Limit — preferred over legacy dye-ingress / microbial-challenge methods.

A step in a food process where control is essential to prevent or eliminate a safety hazard.

CDSCO — Central Drugs Standard Control Organization, the central regulatory authority for drugs, cosmetics + medical devices in India under the Ministry of Health and Family Welfare.

The conformity mark required to place medical devices (and many other products) on the EU/EEA market.

GMP manufacture of cell therapies, gene therapies and combination ATMPs — patient-specific or allogeneic batches with complex chain-of-identity and chain-of-custody.

The QMS process that evaluates, approves, implements and verifies any change to a validated process, system, document or facility.

Documented evidence that a cleaning procedure consistently reduces product residue, cleaning-agent residue and bioburden on shared equipment to scientifically justified, health-based limits between batches.

Software that schedules, executes and records preventive and corrective maintenance on equipment — the maintenance department's system of record.

Processes and systems used by a sponsor (or by the CDMO itself) to govern outsourced manufacturing, tech transfer, batch release and quality oversight.

Lab-signed proof that a specific lot of material met its specification.

Vendor statement that a product meets the agreed specification — lighter than a CoA.

COFEPRIS — Comisión Federal para la Protección contra Riesgos Sanitarios — is Mexico's federal regulatory authority for medicines, medical devices, food, cosmetics, pesticides + tobacco.

Documented evidence — ISTA 7D/7E thermal-cycle tests, summer + winter ambient profiles, route-specific dwell-time analysis and continuous in-shipment loggers — that the chosen container and packing configuration holds a temperature-sensitive product inside its labelled range from release to consignee.

Releasing a batch before all tests are complete — only permitted under specific rules (e.g. PET drugs).

The planned set of controls — on materials, process parameters, in-process tests, finished spec, facility and environment — that together assure the patient-facing CQAs (ICH Q10).

Designated diluent that absorbs the mass delta when an active is recalculated via SBF / LOD / PF / overage so total batch mass holds constant. Must be a true diluent — picking a binder, disintegrant, lubricant, glidant, or release-rate polymer breaks the formulation. Nominated during ICH Q8(R2) QbD formulation development with sensitivity-study evidence.

Short-term process-capability indices — Cp measures spread vs spec, Cpk measures spread vs the nearer spec limit. ≥1.33 is the usual minimum for a controlled process.

The ongoing-monitoring stage of process validation — SPC on CQAs/CPPs across every commercial batch, forever.

FDA's lighter-touch successor to CSV — risk-based, evidence-focused, less documentation.

The formal process of proving a software system does what it should, reliably and predictably.

FSMA 204 — the points in your supply chain where lot history must be captured.

Any written, electronic or oral communication alleging deficiencies in the identity, quality, durability, reliability, safety or performance of a marketed product.

ALCOA+ — data must be Attributable, Legible, Contemporaneous, Original, Accurate (+ Complete, Consistent, Enduring, Available).

Nepal Department of Drug Administration (DDA — औषधि व्यवस्था विभाग — Aushadhi Byabastha Vibhag) operating under the Ministry of Health and Population (MoHP) is the Federal Democratic Republic of Nepal's national regulato…

FDA pathway for novel low-to-moderate-risk devices with no predicate — establishes a new classification rather than going straight to PMA.

The arithmetic of restating measured activity to the activity at a reference time — calibration time, administration time, or expiry. Built on A(t) = A₀ · e^(−λt).

The FDA / ISO design-development discipline — planning, inputs, outputs, review, verification, validation, transfer, changes and the DHF.

The multidimensional, filed combination of CMAs and CPPs proven to deliver acceptable product — movement inside it is not a regulatory change.

Activities that prove design outputs meet design inputs (verification) and that the device meets user needs in actual use (validation).

Approved exception from the procedure — investigated, justified, and signed off.

Bangladesh Directorate General of Drug Administration (DGDA — ঔষধ প্রশাসন অধিদপ্তর — Oushod Proshashon Odhidoptor) operating under the Ministry of Health and Family Welfare (MoHFW) is the People's Republic of Bangladesh'…

The complete design-and-development history of a medical device — required for 510(k) and audits.

Per-unit evidence that one specific medical device was built to its approved DMR.

DIGEMID (Dirección General de Medicamentos, Insumos y Drogas) is the Republic of Peru's national regulatory authority for human medicines + biologicals + vaccines + medical devices + IVDs + sanitary products + drugs of abuse.

DMP (Direction du Médicament et de la Pharmacie — Morocco) is the Kingdom of Morocco's national regulatory authority for human medicines + biologicals + vaccines + medical devices + IVDs + pharmacy practice + cosmetics + drugs of abuse.

The approved master spec for a medical device — what every DHR must reproduce.

The QMS process that creates, reviews, approves, distributes, retrieves and obsoletes controlled documents — SOPs, work instructions, forms, specifications.

Documented verification that the proposed system design meets the URS before you build or buy.

Bhutan Drug Regulatory Authority (DRA — བཙན་ཐབས་ཟས་ཀྱི་ལམ་ལུགས་དབང་འཛིན — operating under Bhutan Medical and Health Council BMHC + Ministry of Health) is the Kingdom of Bhutan's national regulatory authority for human + …

Drug Regulatory Authority of Pakistan (DRAP — ڈرگ ریگولیٹری اتھارٹی آف پاکستان) — operating as autonomous federal authority attached to the Ministry of National Health Services, Regulations and Coordination (M/o NHSR&C) …

How the system is technically built — the lowest validation tier, owned by the supplier.

US law requiring item-level serialisation and electronic traceability across the Rx drug supply chain.

Cryptographic substitute for a wet signature, with re-authentication and meaning bound to the record.

A BMR captured electronically with audit trail and e-signatures instead of paper.

Two routine balance qualification tests: Eccentricity (5-position corner-load test — centre + front-left + front-right + rear-left + rear-right with reference weight 1/3-1/2 of max capacity) proves balance reads same regardless of pan placement; Linearity (5-point span test — 0% + 25% + 50% + 75% + 100% of used range) proves response is proportional across range. Frequency risk-based per ICH Q9 + balance class (weekly/monthly for analytical, monthly/quarterly for bench, quarterly/semi-annual for pallet). Acceptance ≤1/3 of operating tolerance. OOT triggers same back-impact chain as calibration OOT. Environment changes (HVAC service, bench move, nearby equipment) auto-trigger re-test.

EDA — the Egyptian Drug Authority (هيئة الدواء المصرية, Hay'at al-Dawa' al-Misriya) — is Egypt's national regulator for human + veterinary medicines, biologicals, vaccines, blood products, medical devices, in vitro diagnostics (IVDs) + cosmetics.

Electronic, Part 11-compliant DHR — built as the device is built, not retyped after.

Electronic 'heads-up' to the retailer telling them what's on the truck before it arrives.

EFDA (Ethiopian Food and Drug Authority) is the Federal Democratic Republic of Ethiopia's national regulatory authority for human medicines + biologicals + vaccines + medical devices + IVDs + traditional medicines + cosmetics + food + tobacco + drugs of abuse.

EMA — the European Medicines Agency, the decentralised EU agency responsible for the scientific evaluation, supervision + safety monitoring of medicines for human + veterinary use in the European Union + European Economic Area.

LAL or recombinant Factor C (rFC) test for Gram-negative LPS — the per-product limit is K/M (5 EU/kg IV, 0.2 EU/kg intrathecal/ophthalmic) and a fail is a sterile-product release-blocker even when USP <71> passes.

The routine viable air, surface and personnel monitoring plus non-viable particle counts that prove a classified space stays inside its Grade A/B/C/D (EU GMP Annex 1) or ISO 5/7/8 (USP <797>) air classification.

Finance, purchasing, sales, high-level inventory. V5 extends ERP down to the shop floor — no rip-and-replace.

European equivalent of 21 CFR Part 11 — rules for computerised systems in GMP.

Binding EU/EEA standard for wholesale distribution of medicinal products — quality system, Responsible Person, qualified premises and transport, supplier and customer verification, FMD safeguards, returns, recalls, transportation.

EU regulation that replaced the MDD in May 2021 — stricter clinical evidence, expanded scope (includes aesthetic devices), UDI, EUDAMED, mandatory PMS and PSUR.

EU-M4all (EU Medicines for all, formerly the Article 58 procedure) is the European Medicines Agency's scientific-opinion procedure under Article 58 of Regulation (EC) No 726/2004 + EU-M4all Guideline (EMA/CHMP/SAWP/89537…

The kiosk-rendered, sequence-enforced, signature-bound execution surface that replaces paper batch records and PDF-on-tablet SOPs.

The inactive ingredients in a drug — fillers, binders, disintegrants, lubricants, colours, flavours. Cumulatively they're 90%+ of most tablets, and they have their own GMP framework (IPEC-PQG / EXCiPACT).

USP <1663>/<1664> studies that identify compounds the container/closure or single-use system could give up (extractables) and what actually migrates into the drug product over shelf life (leachables).

Ghana FDA — the Food and Drugs Authority — is the Ghanaian national regulatory authority responsible for regulating food, drugs, cosmetics, medical devices, household chemicals, tobacco + blood/blood products in Ghana.

Rwanda FDA is the Republic of Rwanda's national regulatory authority for human + veterinary medicines + vaccines + medical devices + IVDs + cosmetics + processed food + tobacco.

FDA's replacement for 21 CFR 820, harmonising the US device QMS with ISO 13485:2016. Effective 2 February 2026.

Pick the lot with the soonest expiry first — the rule for any perishable or shelf-life-bound material.

Pick the oldest received lot first — used when shelf life isn't the binding constraint.

A cause-and-effect diagram that visually organises potential causes of a problem into categories (often 6M: Man, Machine, Method, Material, Measurement, Mother nature).

Structured risk-analysis tool — list every failure mode, score severity × occurrence × detection, prioritise the high-RPN items. Required content of ISO 14971 for medical devices.

Percentage of units that pass every required inspection without rework on the first attempt. The honest measure of process capability — RTY is the multi-step rollup.

How the system will satisfy each URS requirement — the bridge between business need and technical design.

FDA rule requiring electronic 24-hour traceability for foods on the Food Traceability List.

GFSI-recognised food-safety standard combining ISO 22000, PRP and additional requirements.

The core MSA study — how much of your measurement variation comes from the gauge (repeatability) vs the operator (reproducibility). %GRR < 10% acceptable, 10–30% conditional, > 30% reject.

ISPE's risk-based framework for validating computerised systems in regulated industries.

Toyota / Imai principle that reality is only accurately seen at the place where value is created — and the gemba walk is the structured leadership practice (observe → ask → coach → commit → follow-through) that operationalises ICH Q10 + 21 CFR 820.20 management responsibility with auditable evidence.

Toyota Way Principle 12 — Liker 2004 — 'go and see for yourself to thoroughly understand the situation.' The philosophical engine under gemba walks, A3 authoring, root-cause analysis and 820.20 / ICH Q10 §2.7 / ISO 13485 §5.6 management responsibility: decisions about work are made at the work, not from descriptions of it.

The bidirectional graph of which raw lot fed which intermediate fed which finished lot, on which equipment, by which operator — the dataset behind every recall and investigation.

The umbrella body that benchmarks food-safety standards (SQF, BRCGS, FSSC 22000, IFS).

The best-ever (or statistically-best-ever) run of a product, captured as a multi-variate fingerprint of every CPP / IPQ / KPI and used as the live reference trajectory new batches are scored against in real time.

Barcode standard that encodes lot, expiry, qty and GTIN in one scan — the foundation of license-plate inventory.

GS1's globally unique product identifier — the 'product' part of every retail barcode.

Umbrella term — GMP (manufacturing), GLP (lab), GCP (clinical), GDP (distribution).

Food-safety framework that identifies hazards and the critical points where they must be controlled.

The time for a radioactive substance to decay to half its initial activity. Drives every aspect of radiopharma manufacturing — calibration time, dispense time, shipping, dosing.

The FSMA hazard-analysis framework that supersedes traditional HACCP for FDA-regulated foods. Broader scope — includes economic adulteration, radiological hazards, supply-chain controls.

Health Canada — the Canadian federal department responsible for national public health, regulating therapeutic products through the Health Products and Food Branch (HPFB).

Toyota's discipline of distributing volume + product mix evenly across the planning horizon so the line genuinely runs to takt — the prerequisite that makes pull systems, kanban and just-in-time real rather than aspirational.

US law protecting individually identifiable health information (PHI). Pharma manufacturers usually aren't covered entities, but radiopharma sites handling patient-dose data often are or have a BAA.

Toyota / Bridgestone / HP discipline that converts 3-5 year breakthrough objectives into year-by-year, department-by-department, team-by-team measurable commitments — via the X-matrix, catchball negotiation, and monthly review — so strategy becomes daily work rather than shelfware.

HSA — Singapore's Health Sciences Authority — the national competent authority for therapeutic products, medical devices, complementary health products, cosmetics, cellular + tissue therapies, blood + the national forensic science service.

The engineering discipline of designing devices for the user, environment and task — with the goal of minimising use-related risk.

Framework for assessing and controlling potentially mutagenic / carcinogenic impurities — five-class (Q)SAR classification, default TTC of 1.5 µg/day, compound-specific AIs for the cohort of concern (nitrosamines, aflatoxins, alkyl-azoxy).

The international model for a Pharmaceutical Quality System covering the entire product lifecycle from development to discontinuation.

Development and Manufacture of Drug Substances — the harmonised ICH guideline that defines what regulators expect in the drug-substance (API) section of the eCTD Module 3.2.S of a marketing-authorisation dossier.

International standard for proving an analytical method does what it claims — specificity, accuracy, precision, linearity, range, LOD, LOQ, robustness.

The harmonised, risk-based framework for controlling 24 named elemental impurities against route-of-administration PDEs — replacing the legacy USP <231> colorimetric heavy-metals test.

International framework for setting drug substance and drug product specifications — what to test for, at what stage, and what limits to apply.

The international GMP standard for API manufacture — adopted as FDA guidance and EU GMP Part II.

International guideline that mandates risk-based decision-making across the pharma product lifecycle. Underpins everything from supplier qualification to PPQ batch count.

Foundational electrical-safety and EMC standard for medical electrical equipment — required for virtually every powered medical device.

International standard for medical device software lifecycle — required for software in a device (SiMD) and software as a medical device (SaMD).

The usability-engineering standard for medical devices — analyse use, identify use-related hazards, design to mitigate, validate with representative users. Required under MDR, IVDR and FDA QMSR.

Iran Food and Drug Administration (IFDA — سازمان غذا و دارو — Sazman-e Ghaza va Daru) — operating as autonomous deputy organisation of the Ministry of Health and Medical Education (MoHME — وزارت بهداشت، درمان و آموزش پزش…

Mid-batch closure step where mass / count / volume at a process stage is reconciled against scaled theoretical before progression: Σ in − Σ out − Σ authorised loss = Δ; |Δ| ≤ stage tolerance. Distinct from IPC (tests CQAs) and from end-of-batch yield reconciliation (closes whole batch). 21 CFR 211.103 requires yield calculation 'at the conclusion of each appropriate phase' — explicitly stage-by-stage, not only end-of-batch.

INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) is the Republic of Colombia's national regulatory authority for human + veterinary medicines + biologicals + vaccines + medical devices + IVDs + cosme…

The three qualification stages that prove a system is installed, operating, and performing as intended.

The standard for batch manufacturing: physical model, procedural model, the four recipe types, and the Part-4 batch production record.

The reference model that defines the five-level pyramid (ERP → MES → SCADA → PLC → process) and the ERP-to-MES integration contract.

The biocompatibility standards series for medical devices — what tests are required for what type/duration of body contact. FDA recognises ISO 10993-1:2018 with a modified matrix.

International QMS standard for medical-device manufacturers — recognised globally.

The risk-management standard for medical devices — mandated by FDA QMSR, MDR, IVDR and ISO 13485. Risk file, hazard analysis, risk control, residual-risk evaluation, risk-management report.

The international standard that defines OEE, NEE, TEEP, FPY, RFT, MTBF, MTTR and the rest of the MOM KPI catalogue with formulas, units and a formal time model.

International standard for the metrological performance, marking, testing and conformity of piston-operated pipettes, burettes and dispensers.

Generic international QMS standard — the foundation almost every industry-specific standard builds on.

A systematic, independent and documented audit conducted against an ISO management-system standard — internal (1st-party), supplier (2nd-party) or certification body (3rd-party).

ISP (Instituto de Salud Pública de Chile) is the Republic of Chile's national regulatory authority for human medicines + biologicals + vaccines + medical devices + IVDs + cosmetics + occupational health + drugs of abuse + environmental health.

EU regulation for in-vitro diagnostic devices — applied May 2022, brought ~85% of IVDs under Notified-Body oversight (vs ~20% under the old IVDD).

JFDA (Jordan Food and Drug Administration) is the Hashemite Kingdom of Jordan's autonomous national regulatory authority for human medicines + biologicals + vaccines + medical devices + IVDs + cosmetics + food + dietary …

Toyota's second pillar (alongside JIT) — build intelligence into operator + equipment so the moment an abnormality appears the line stops, the defect is contained, the cause is fixed and standardised, and nothing defective is passed downstream.

Imai / Toyota continuous-improvement philosophy: small, daily, operator-led changes — structured by PDCA, A3 and kaizen events, sustained by 30/60/90-day audits, and proven by CAPA-effectiveness — compound into long-term performance that strategic breakthroughs alone never deliver.

Toyota's visual pull-signal system that triggers production / replenishment only when downstream demand consumes it — and physically caps work-in-progress so overproduction stops being a discipline problem and becomes a system invariant.

FSMA 204 — the specific data points you must capture at each tracking event.

Second pillar of the JIPM 8-pillar TPM model — Nakajima 1988 — chartered cross-functional 60–120-day attack on a single named chronic loss using the 16-loss taxonomy + 10-step PDCA + PM analysis, complementing daily kaizen and producing the auditable ICH Q10 §3.2.4 / 820.100 continual-improvement evidence regulators expect.

Lab-side system that owns samples, instruments, methods, results, OOS, CoA.

Documented inspection that a production line is empty of the previous product and ready for the next — the single biggest defence against allergen cross-contact and mix-up.

The periodic executive review by which top management owns the QMS — required by 21 CFR 820.20(c), ISO 9001 §9.3, ISO 13485 §5.6, ICH Q10 §2.6 and EU GMP Ch 1 §1.4(xv).

Single QMS audit recognised by five regulators — FDA (US), Health Canada, ANVISA (Brazil), TGA (Australia), PMDA (Japan). One audit instead of five.

FDA's voluntary adverse-event and product-problem reporting system for healthcare professionals, patients and consumers (Form 3500).

The system that runs the shop floor — work orders, dispense, weigh, blend, package, label.

MFDS — Ministry of Food and Drug Safety (식품의약품안전처) — South Korea's central regulatory authority for foods, pharmaceuticals, biologics, medical devices, cosmetics + quasi-drugs.

MHLW — Ministry of Health, Labour and Welfare (厚生労働省, Kōsei-rōdō-shō) — is Japan's national government ministry responsible for health, social welfare, labour + pensions policy + the legal owner of marketing-authorisatio…

The UK's regulator for medicines, medical devices and blood components — operating post-Brexit under UK MDR 2002 and the Human Medicines Regulations 2012.

Smallest mass on a given balance that meets USP <41>'s ≤0.10% relative repeatability target, computed as (2 × σ_rep × k) ÷ 0.001. σ_rep is the MEASURED repeatability under actual use conditions (NOT spec-sheet). k is a documented QRM decision per ICH Q9(R1) — typically 2 routine, 3 conservative, 5+ for high-potency. The 1× to 1.5× caution band requires heightened controls. Post-PF/SBF/LOD/overage cascade must re-check min-weight against the adjusted target (a 500 mg nominal can shrink to 45 mg post-adjustment and fall below the floor). Sub-min-weight is a database-layer hard block; splitting to evade is NOT a workaround.

The approved master recipe and process every batch must reproduce exactly.

2022 US law that put cosmetics under FDA oversight — facility registration, product listings, adverse-event reporting.

Iraq MoH (Ministry of Health — Republic of Iraq) — operating through the Iraqi Technical Affairs Directorate + the Kimadia State Company for Marketing Drugs and Medical Appliances + the National Center for Drug Control a…

Israel Ministry of Health (משרד הבריאות — Misrad HaBriut) — operating through the Pharmaceutical Administration (אגף הרוקחות — Agaf HaRokchut) + the Institute for Standardization and Control of Pharmaceuticals (ISCP — Ma…

Kuwait MoH (Ministry of Health — State of Kuwait) — operating through the Drug & Food Control Administration (DFC) and the Kuwait Drug and Food Control (KDFC) — is the national regulatory authority for human medicines + …

Oman MoH (Ministry of Health — Sultanate of Oman) — operating through the Directorate General of Pharmaceutical Affairs and Drug Control (DGPA&DC) — is the national regulatory authority for human medicines + biologicals …

Palestine MoH (Wizārat al-Siḥḥa al-Filasṭīniyya) — operating through the Pharmaceutical General Administration (PGA) + Central Public Health Laboratory (CPHL) + Palestinian National Pharmacovigilance Centre — is the Stat…

Syria MoH (Ministry of Health — Syrian Arab Republic) — operating through the Directorate of Pharmaceutical Affairs (DPA) + the Syrian Drug Quality Control & Research Laboratory (SDQC&RL) + the Syrian Pharmacovigilance C…

MoHAP (Ministry of Health and Prevention — United Arab Emirates) is the federal regulatory authority for human medicines + biologicals + vaccines + medical devices + IVDs + cosmetics + dietary supplements + pharmacy prac…

ISA-95 Part 3's umbrella term for everything at Level 3: production, quality, maintenance and inventory operations.

Afghanistan Ministry of Public Health (MoPH — وزارت صحت عامه — Wezarat-e Sehat-e Aama) operating through the General Directorate of Pharmaceutical Affairs (GDPA) + the National Medicines and Healthcare Products Regulator…

Lebanon MoPH (Ministry of Public Health — Lebanese Republic) — operating through the Pharmaceutical Directorate + the Quality Assurance of Pharmaceutical Products Department (QAPP) + the Central Laboratory for Drug Contr…

Qatar MoPH (Ministry of Public Health — State of Qatar) — operating through the Department of Pharmacy and Drug Control (DPDC) — is the national regulatory authority for human medicines + biologicals + vaccines + medical…

The discipline of proving your measurement system is good enough to trust the numbers it gives you — bias, linearity, stability, repeatability, reproducibility.

Standardised 16-section hazard document required for every hazardous chemical (OSHA HazCom 2012 / GHS).

NAFDAC — the National Agency for Food and Drug Administration and Control — is Nigeria's federal regulatory authority responsible for regulating + controlling the manufacture, importation, exportation, distribution, adve…

Formal record of something out-of-spec — material, process, product or document.

Uganda NDA — the National Drug Authority — is the Republic of Uganda's national regulatory authority responsible for ensuring availability at all times of essential, efficacious + cost-effective drugs to the entire popul…

Toyota Way Principle 13 — structured one-on-one groundwork that surfaces every stakeholder's concerns and refines the proposal before the formal decision meeting, so the meeting confirms an aligned outcome and implementation begins immediately.

Per-charge accounting of every gram between balance reading (GROSS = pan + container + tooling), formula-relevant mass (NET = gross − tare), and warehouse pick (ISSUED). Every issued-vs-charged gap must map to one of six PPQ-validated authorised loss categories: container residue / tooling carry-over / spill-dust / sample-IPC retention / returned-to-inventory (paired transaction required) / scrap-quarantine. End-of-batch aggregation hides per-charge over/under-issues that cancel in summary; per-charge live ledger is the only defensible approach. Mid-batch envelope breach hard-stops next charge until QA dispositions. Per-component running ledger green/amber/red with RLS-enforced hard-stop on red. §211.188(b)(11) + 211.184 + 111.260(g) + 111.310 + EU GMP Ch.5 §5.40-§5.43 + ICH Q7 §6.5 explicit; 'unaccounted' is a §211.192 finding, not a category.

NHRA (National Health Regulatory Authority — Kingdom of Bahrain) is the autonomous national regulatory authority for human medicines + biologicals + vaccines + medical devices + IVDs + cosmetics + dietary supplements + h…

The post-2018 EMA/FDA programme requiring every chemical drug-product holder to risk-assess, confirm and control N-nitrosamines (NDMA, NDEA, NDSRIs) against ICH M7-derived Acceptable Intakes.

China's regulatory authority for drugs, medical devices and cosmetics — successor to CFDA, operating under the Drug Administration Law and Medical Device Regulations.

Sri Lanka National Medicines Regulatory Authority (NMRA — ජාතික ඖෂධ නියාමන අධිකාරිය — Jathika Awushadha Niyamana Adhikariya / தேசிய மருந்து ஒழுங்குபடுத்தும் அதிகாரசபை — Thesiya Marunthu Ozhungupaduthum Adhikarasapai) ope…

An EU-designated conformity-assessment organisation that audits manufacturers and dossiers under MDR/IVDR before CE Marking can be applied.

The US federal agency that regulates the civilian use of radioactive materials — licences, ALARA limits, training, security, transport, waste. Most radiopharma sites operate under an NRC (or Agreement-State) licence.

Toyota cross-functional war room — co-located programme team in one room walled with persistent visual management (schedule, issues, risks, A3s, KPIs), reviewed in daily/weekly/monthly cadence with decision authority present, so cross-functional communication latency collapses from days to minutes.

Availability × Performance × Quality — the standard line/asset productivity metric.

Toxicology-derived airborne-exposure limit for an API (OEL, µg/m³) and the banded category (OEB 1–5/6) used to specify containment and PPE.

Lab result that fails its acceptance spec — triggers a regulated investigation.

Lab result inside spec but drifting — early warning of process drift.

Deliberate excess of active added at formulation so the product still meets label claim at end of shelf life. Decomposed into manufacturing overage (PPQ-bounded loss compensation) and stability overage (decay-curve-bounded). EMA flags combined >5% as exception requiring Module 3 justification; FDA treats overage used to mask process problems as a §211.100 violation.

The FDA 2004 framework for designing, analysing and controlling manufacturing through timely (in-, on- or at-line) measurements of CQAs and CPPs — enabling real-time control and, where filed, RTRT.

The FSMA-mandated qualified person who develops or oversees the Food Safety Plan under 21 CFR 117. Training via FSPCA standard curriculum (or equivalent).

EU cosmetic regulation requirement — the dossier the Responsible Person must keep for every product.

FDA's most rigorous device approval pathway — required for Class III (high-risk) devices. Clinical trials, full design-and-mfg dossier, six-figure user fee.

Japan's regulatory agency for pharmaceuticals, medical devices, regenerative medicines and cosmetics — operating under the PMD Act.

Active, systematic collection of device performance & safety data after market release — required under MDR/IVDR (mandatory PSUR for higher classes) and FDA 803/806/822.

Shigeo Shingo's discipline of engineering the work so a defect either cannot occur (prevention) or cannot escape (detection) — replacing the unworkable "be more careful" strategy with mechanical, electrical or system devices that make the wrong action either physically impossible or immediately obvious.

Post-Market Surveillance — the lifelong, proactive, documented programme of collecting and acting on real-world performance and safety data after a device is on the market.

The dimensionless multiplier applied to a nominal target weight to correct for measured lot potency vs reference. PF = reference potency ÷ measured potency, on the same basis (anhydrous, free-base, dry). The core input to every assay-adjusted dispense and the lot attribute auditors trace first.

Long-term process-performance indices — same formula as Cp/Cpk but using overall (long-term) sigma. The honest number for ongoing capability.

Kenya PPB — the Pharmacy and Poisons Board — is Kenya's national regulatory authority responsible for regulating the practice of pharmacy + the manufacture + trade in drugs + poisons + medical devices + health technologies in Kenya.

The validation stage that proves the commercial manufacturing process consistently produces in-spec product — usually three consecutive successful batches.

A legally-marketed device used as the comparator in a 510(k) substantial-equivalence determination.

End-to-end lifecycle — Stage 1 Process Design, Stage 2 Process Performance Qualification (PPQ), Stage 3 Continued Process Verification (CPV) — that establishes and maintains a commercial manufacturing process in a state of control under the FDA 2011 (rev. 2024) guidance and EU GMP Annex 15.

The ICH Q8(R2) framework that builds quality into the product and process via QTPP, CQAs, CMAs/CPPs, design space and a control strategy — instead of inspecting it in at QC release.

Audits, NCR/CAPA, deviations, complaints, supplier quality, document control.

EU GMP — only a named Qualified Person can certify a batch for market release.

Access-control model where permissions are assigned to roles, and users are assigned to roles — not permissions assigned directly to users. The minimum bar for any Part 11 / Annex 11 system.

Part 11 / Annex 11 dual-control e-sig that authorises any post-close recomputation of a regulated derived calculation (PF / LOD / SBF / counter-balance / scaled theoretical / actual_net / yield %). Original value is NEVER overwritten — preserved in audit trail, rendered side-by-side on regenerated PDF. Paired deviation always opened; impact assessment always required; CAPA opened on cross-batch scope. Observations (weights, meter readings, QC results) follow §211.68 / Annex 11 §9 annotation path — not recalculation.

The lean / six-sigma metric that combines yield, rework and rejects into a single 'made it correctly the first time' percentage. Cousin of FPY at the batch / order level.

NRC limits for releasing radioactive materials from licensed sites — surface ≤ 2× background, removable ≤ 1000 dpm/100cm².

A grid of likelihood × consequence used to score and rank risks for prioritised treatment — the workhorse of ISO 31000-style risk management.

Structured investigation to identify the underlying cause(s) of a problem so corrective action eliminates recurrence — not just the symptom.

Roszdravnadzor (Федеральная служба по надзору в сфере здравоохранения / Federal Service for Surveillance in Healthcare, abbreviated RZN or Росздравнадзор) is Russia's federal supervisory authority for medicines, medical …

The ordered sequence of operations (steps, equipment, labour, times) required to convert the BOM into finished product. With the BOM, defines the cost and the process.

SAHPRA — the South African Health Products Regulatory Authority — is South Africa's national regulator for medicines, medical devices, in vitro diagnostics (IVDs), complementary medicines, veterinary medicines, radiation-emitting devices + clinical trials.

Dimensionless molecular-weight ratio applied at dispense when the API is supplied as a salt but the label claim is the free base. SBF = MW(salt) ÷ MW(base); adjusted target = label claim × SBF. Skip it and the batch is silently 5–30% under-strength — by far the largest single-step silent sub-potency failure mode in solid-dose pharma.

Yemen SBDMA (Supreme Board of Drugs and Medical Appliances — al-Hay'a al-'Ulya li-l-Adwiya wa-l-Mustalzamāt al-Tibbiyya) — operating under the Ministry of Public Health and Population (MoPHP) Republic of Yemen — is the n…

Saudi SFDA — the Saudi Food and Drug Authority (الهيئة العامة للغذاء والدواء) — the Kingdom of Saudi Arabia's central regulatory authority for foods, drugs, medical devices, cosmetics, pesticides + veterinary products.

Shigeo Shingo's methodology for cutting equipment changeover time to under 10 minutes — the foundation of lean small-batch / mixed-model production.

AICPA audit standard covering security, availability, processing integrity, confidentiality and privacy. Type I = controls designed; Type II = controls operating effectively over ≥6 months.

Controlled procedure document — versioned, reviewed, training-acknowledged.

Charts that detect process drift before it becomes a failure — Shewhart, CUSUM, EWMA.

Engineered + procedural + detection barrier stack that stops material from one product reaching another product's batch (or operator) during weighing, dispense, transfer, sieving, clean-down. Five vectors (airborne / surface / personnel / tooling / material-flow) — each answered by at least one engineered + procedural + detection control. Every spill is a controlled deviation under §211.100 with 8-step chain (isolate / assess / contain / decontaminate / quarantine / investigate / CAPA / close-verify). Every product changeover is a validated matrix event with PDE-derived acceptance limits + ATP/TOC/HPLC swab against worst-case product. §211.176 penicillin + cytotoxic + hormone + live-biologic = dedicated facility (bright line). Cleaning validation = 3 successful runs + continuous surveillance + event-driven re-validation. Paper spill-books are critical observations; matrix-driven kiosk enforcement + RLS-locked changeover is the defensible architecture.

GFSI-recognised food-safety standard widely used in the US — SQFI runs the program.

GS1's 18-digit unique pallet ID — one SSCC per outbound pallet for EDI 856 ASN.

Federated authentication — users sign in once to the corporate IdP and the application receives a signed assertion. SAML 2.0 and OIDC are the two dominant standards.

Written sanitation procedures required under USDA-FSIS (9 CFR 416) and FDA cGMP — pre-op and operational sanitation, monitoring, corrective actions, records.

ICH Q1A(R2) long-term, intermediate and accelerated studies on three primary batches in market packaging that establish a drug's shelf life — plus the annual on-going stability commitment after launch.

Toyota's foundation under kaizen — the currently one-best-known method for each operator task at takt, captured by the team leader + operators in three artefacts (takt + sequence + standard WIP), used as the training + audit + jidoka baseline, and replaced whenever kaizen finds better.

Five-layer engineered + procedural control set that stops triboelectric / electrostatic charge from corrupting low-mass weighments: (1) environment — RH 40-60% with continuous monitoring + alarming, the 40% break-point below which charge accumulates faster than it dissipates; (2) ionisation — alpha or corona ioniser at the balance + storage cabinet with monthly balanced-output test ≤±35 V; (3) grounding — anti-static dissipative mat grounded to building earth + grounded balance + operator wrist-strap with daily continuity test; (4) materials — conductive weigh-boats + stainless scoops + conductive tweezers + cotton lab coats; (5) procedure — operator pre-flight 6-check before first weighment of shift. Sub-40% RH auto-enables ESD-elevated mode (mandatory ionisation dwell + conductive-only tooling). §211.192 low-mass OOS investigations must explicitly disposition ESD contribution — the most-misattributed root cause that surfaces as 'operator technique' in poorly-controlled programs.

The 14-day compendial sterility test (FTM + SCDM, direct inoculation or membrane filtration) — narrow statistical power, but still the regulatory release gate for sterile products.

Risk-based, documented process — risk assessment, questionnaires, on-site audit, three qualifying lots, signed Quality Agreement under EU GMP Chapter 7 — that establishes a supplier can consistently meet specification before they appear on the Approved Supplier List.

Risk-based process of qualifying, monitoring and re-evaluating suppliers based on the criticality of what they supply and their performance history.

A periodic, weighted rating of each supplier on quality, on-time delivery, responsiveness and audit results — drives requalification and tier changes.

Enterprise-level identification, assessment and mitigation of risks across the end-to-end supply chain — single-source dependencies, geopolitical, logistics, cyber.

Swissmedic — the Swiss Agency for Therapeutic Products (Schweizerisches Heilmittelinstitut / Institut suisse des produits thérapeutiques) — Switzerland's national competent authority for medicines + medical devices.

TACCP = food defence (deliberate attack, e.g. tampering, terrorism). VACCP = food fraud (economically-motivated adulteration). Required by GFSI schemes (BRCGS, SQF, FSSC 22000).

The pace of customer demand expressed as time per unit — available production time ÷ required output. The heartbeat of every levelled (heijunka) production line.

Pre-charge zero capture + drift check that turns a raw balance reading into a defensible regulated net mass. Five events: pre-tare zero, tare capture, stability dwell, gross capture, post-tare drift check. Container_id is bound to the tare event at capture; container swap or open-and-close cycle forces re-tare (hard block, not soft warning). Stability checked from live data feed not display. Drift envelope is balance-class + weighment-specific. Cross-balance net is prohibited (gross + tare must come from the same balance + same calibration window). Critical charges require §211.101(c) distinct-user witness e-sig.

The formal handover of a product, process or method from one site / unit to another — the riskiest activity in a pharma network. Governed by ICH Q10 §3.2.3 and WHO TRS 961 Annex 7.

EU MDR/IVDR documentation package covering device description, design, manufacturing, risk, clinical evidence, labelling and PMS.

Distributed-probe qualification of a storage area, vehicle or chamber that proves the labelled temperature is held everywhere, under load, through summer and winter — and that justifies where the routine continuous monitor probe sits.

TFDA — Taiwan Food and Drug Administration (衛生福利部食品藥物管理署, Wèishēng Fúlì Bù Shíwù Yàowù Guǎnlǐ Shǔ) — is Taiwan's national regulatory authority for foods, drugs, medical devices, cosmetics + controlled substances.

Australia's regulator for therapeutic goods — medicines, medical devices, biologicals, blood and tissues — operating under the Therapeutic Goods Act 1989.

End-of-batch closure ratio: actual_net ÷ scaled_theoretical × 100. Denominator is the YA-scaled theoretical from the WO snapshot, NEVER the nominal MMR. Numerator is actual_gross minus IPC samples / retain samples / validated hold-up / dust extraction / line-clearance discards / weight-rejected units — never gross. §211.110(a)(4) envelope is bidirectional: too-low triggers a deviation for material loss; too-high triggers a deviation for measurement error or wrong MMR theoretical. §211.192 review e-sig closes the batch, dual-control with preparer.

Türkiye TİTCK (Türkiye İlaç ve Tıbbi Cihaz Kurumu — Turkish Medicines and Medical Devices Agency) — operating under the Ministry of Health of the Republic of Türkiye (Türkiye Cumhuriyeti Sağlık Bakanlığı) — is the Republ…

Tanzania TMDA — the Tanzania Medicines and Medical Devices Authority — is the United Republic of Tanzania's national regulatory authority responsible for the regulation of medicines + medical devices + in-vitro diagnostics + cosmetics + tobacco products.

Nakajima / JIPM's 8-pillar framework that turns equipment effectiveness into a production-wide responsibility — operator-owned autonomous maintenance + planned maintenance + focused improvement + OEE measurement, targeting zero breakdowns / zero defects / zero accidents.

The grid that maps every URS requirement to the FS, DS, test script and test result that proves it works — your single audit defence.

Per-person evidence that an operator has been trained on the current version of every SOP they execute.

Preparer + independent reviewer — required for MMRs and many GMP approvals.

FDA-mandated unique ID on every medical device — submitted to GUDID.

The document that captures what the business actually needs the system to do — the anchor for every later validation test.

The official compendium of drug-substance, excipient and dosage-form quality standards in the US. USP–NF monographs are enforceable by FDA under FD&C §501.

USP General Chapter <788> — sub-visible particle test for injectables: Method 1 (light obscuration) or Method 2 (microscopic membrane), counts at ≥10 µm and ≥25 µm, with SVP (per container ≤100 mL) and LVP (per mL >100 mL) compendial limits.

USP General Chapter <797> — the standard for compounded sterile preparations (CSPs). Sets environment classification, garbing, beyond-use dating by category, environmental monitoring and gloved-fingertip + media-fill competency for every compounder.

USP General Chapter <800> — containment standard for the NIOSH hazardous-drug list across all of healthcare: receipt, storage, sterile + non-sterile compounding, administration, transport, spills and waste.

Toyota / Rother+Shook analytical method (Learning to See, 1999) that draws current-state + future-state flow of material + information across an entire value stream on one page, exposes the 7 wastes, and sequences the kaizen implementation plan that closes the gap.

The site-level document that lists every system, process and piece of equipment requiring validation, who owns it, and when.

Arithmetic correction at dispense when formula and CoA use different moisture bases. As-charged target = anhydrous-basis target ÷ (1 − LOD). Loss-on-Drying (USP <731>) and Karl Fischer (USP <921>) are not interchangeable — substituting LOD where KF is specified is a recurring §211.84 violation. Hygroscopicity class (USP <1241>) drives shelf-life-after-open re-test policy.

Explicit ± window around a §211.101 charge target inside which a weighment is accepted, outside which it is routed to deterministic low/high handlers (top-off, re-weigh, return-to-source, deviation, scrap). Has a unit (absolute g OR percent of target — never ambiguous), a direction (symmetric ±x or asymmetric +a / −b where one-sided risk dominates), and routing per edge. Set during development from formulation tolerance + analytical method variability + balance capability + ICH Q9(R1) QRM. Captured on the MMR, enforced server-side against the POST-adjustment target (not nominal), and locked under change-control. Operator override is never exposed in the kiosk.

WHO Prequalification (PQ) — the World Health Organization programme that assesses the quality, safety + efficacy of priority medicines, vaccines, in-vitro diagnostics (IVDs), vector-control products + active pharmaceutic…

Inventory currently between raw and finished — partially-processed material that has consumed cost but not yet generated revenue.

Receiving, putaway, lots/serials, bins, transfers, picking, shipping — the inventory layer.

The authorised instruction to manufacture a specific quantity of a specific product on a specific date — the unit of work tracked through the shop floor.

The signed batch-close calculation comparing theoretical yield vs actual yield. Variance outside limits triggers an investigation under 21 CFR 211.103 / 111.310.

Planned batch size re-scaled before dispense begins (input shortage, vessel ceiling, sub-potent active, equipment downtime, clinical scale-down). Must be inside the validated batch-size range on the MMR or it's a change-control event. Scale first, then PF / LOD / SBF / counter-balance — wrong order breaks the diluent figure. Two-person e-sig at WO release under 21 CFR 211.100 + 211.186; kiosk operators cannot scale unilaterally.

Toyota / lean discipline of systematically deploying a validated countermeasure or learning to every other process where the same mechanism exists — adapted per target, signed off per target, sustain-audited per target — and the structural answer to 21 CFR 820.100(a)(4) 'similar nonconformances' requirement. The most-skipped step in Western lean and the difference between compounding kaizen and a collection of one-line wins.